|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S2
|
$50,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of IRF8 in Tumor Rejection and Suppression
|
5R01CA133085-08
|
$307,800
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression
|
5R01CA182518-04
|
$315,400
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
Role of Sympathetic Activation and RANKL/IL6 in Breast Cancer Bone Metastasis
|
5R01CA168717-05
|
$323,700
|
ELEFTERIOU, FLORENT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-01S1
|
$14,309
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-04
|
$2,300,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
5R01CA181808-04
|
$336,565
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
5R01CA174808-04
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
|
1R03CA215940-01
|
$75,288
|
YUSTEIN, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer
|
5R01CA202797-02
|
$352,363
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-13
|
$2,300,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
5P01CA174645-05
|
$1,209,609
|
MCDANNOLD, NATHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-18
|
$2,424,605
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-03
|
$2,403,338
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Epigenetically Reversing Paclitaxel Resistance in Triple Negative Breast Cancers
|
1F32CA210426-01A1
|
$61,866
|
GAYLE, SYLVIA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
|
5R21CA209304-02
|
$206,843
|
GREENFIELD, EDWARD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
|
1R21CA218790-01
|
$208,637
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-03
|
$617,516
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Image-guided EMT inhibition for treating metastatic breast cancer
|
5R01CA194518-03
|
$473,853
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
2P50CA150964-06A1
|
$2,375,000
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
|
5F30CA186633-04
|
$49,044
|
MORROW, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Dual-pronged nano-drug delivery using plant virus-like particles
|
1R01CA224605-01A1
|
$470,066
|
STEINMETZ, NICOLE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology
|
1U01CA218292-01
|
$616,764
|
STEINMETZ, NICOLE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of CRABP-II in pancreatic cancer metastasis
|
1R03CA201738-01A1
|
$80,000
|
YU, SHUILIANG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
|
5K08CA179084-04
|
$113,074
|
YANG, SUN
|
CHAPMAN UNIVERSITY
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143931-08
|
$1,808,575
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
Cytokine- and Satellite Cell-mediated Muscle Disease Promotion
|
5R01CA189299-03
|
$337,941
|
KELLER, CHARLES
|
CHILDREN'S CANCER THERAPY DEVELOP/INST
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
5R01CA168452-05
|
$259,058
|
CHOU, MARGARET
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Exosomes in tumor cell-mesenchymal stromal cell interaction
|
1R01CA207983-01A1
|
$423,016
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Training Physician Scientists in Pediatric Oncology
|
5T32CA009659-22
|
$136,153
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
|
1P01CA217959-01
|
$2,296,936
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Early Phase Clinical Trials in Imaging and Image-Guided Interventions
|
5R01CA197137-03
|
$235,564
|
KIM, AERANG
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
|
1R01CA211098-01A1
|
$431,066
|
FLICK, MATTHEW
|
CINCINNATI CHILDRENS HOSP MED CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|